Summary of Ben McKenzie vs. crypto

Overview of Ben McKenzie vs. crypto (The VergeCast episode)

This VergeCast episode (host David Pierce) features two long interviews and a hotline segment. First, actor/author Ben McKenzie discusses his new documentary Everyone Is Lying to You for Money and lays out why he thinks much of crypto is a scam — covering technology limits, trust myths, high-profile frauds, and the culture around crypto. Second, The Verge senior reviewer V (V Song) explains continuous glucose monitors (CGMs): what they measure, why they’ve gone mainstream since FDA over‑the‑counter clearance, her 18‑month personal experiment wearing multiple CGMs, the psychological and medical harms she encountered, and the policy/industry forces shaping the trend. The show closes with a listener question about why modern gadgets look and feel so homogenized.

Key points & main takeaways

• Crypto

  • Crypto is both about money and about narratives/gambling; its core pitch (“trustless money”) is flawed because code is written by humans and people still make/manipulate systems.
  • Technology limits: Bitcoin’s throughput (5–7 tx/sec) is far below Visa; other chains trade speed for security and have been vulnerable to hacks.
  • Real-world test failed: El Salvador’s Bitcoin experiment didn’t work as money for ordinary Salvadorans (remittances remain tiny share; infrastructure/usability problems).
  • Major scams and centralized control: cases like Celsius and FTX show how corporate actors and one-line code changes can enable theft; many “decentralized” projects are in fact centralized.
  • Crypto is mostly a speculative/gambling ecosystem and a facilitator of crime (examples: sanctions evasion, stolen funds, alleged funding to bad actors).
  • Market durability: political endorsement, whale control, and mania dynamics keep prices supported despite scandals.
  • Broader critique: crypto highlights legitimate failures of regulated financial systems but is not a substitute for public money or better democratic oversight.

• CGMs and wearables

  • What CGMs measure: interstitial glucose (not direct blood glucose); devices historically for diabetics now cleared OTC for non‑diabetics (2024).
  • Mainstreaming drivers: FDA clearance, wellness/metabolism optimization marketing, high‑profile political and industry advocacy (e.g., RFK Jr., partnerships, startup influence).
  • V Song’s experience: prolonged, obsessive self‑tracking with conflicting device readings; alarm‑driven behavior led to disordered eating patterns, anxiety, and ultimately medical prescriptions with serious side effects.
  • Data interpretation problem: lack of clinical consensus for non‑diabetics; endocrinologists often disagree on how to act on CGM reports for people without diabetes.
  • Risks & benefits: CGMs are life‑saving for type‑1 diabetics and can identify real metabolic issues, but everyday use by healthy people can cause harm (anxiety, disordered eating), and mainstream demand can harm supply/access (e.g., shortages affecting diabetics).
  • Policy tension: lobbying for relaxed device categories (digital screeners) vs. need for robust regulation and clinical standards; wearables intersect with politics and profit motives.

• Gadgets/homogenization

  • Convergence in design arises from user inertia, economies of scale, and lack of forcing‑function new technologies; radical redesigns are risky and expensive.

Topics discussed

• Ben McKenzie

  • The premise and findings of Everyone Is Lying to You for Money.
  • Why “trustless” crypto is a misnomer (code → people → trust).
  • Bitcoin’s technical limits and scaling claims.
  • Investigations into Celsius, FTX, Sam Bankman‑Fried, and other frauds.
  • El Salvador’s failed Bitcoin rollout and why it matters.
  • Crypto culture: demographics, gambling mentality, cultish behavior.
  • Crime enabled by crypto: sanctions circumvention, ransomware/North Korea, shady funding.
  • Why crypto persists despite repeated scandals (political endorsements, whales, market psychology).

• V Song (CGMs)

  • Technical basics of CGMs (interstitial glucose; device differences such as Dexcom/Stelo and Abbott Lingo).
  • FDA OTC change (2024) and implications.
  • Personal narrative: PCOS, family history of diabetes, NutriSense in 2023, side‑by‑side device testing in 2024, diagnosis of mild fatty liver disease, treatment side effects.
  • Psychological effects: data obsession, disordered eating patterns, therapy intervention.
  • Clinical and regulatory gaps: inconsistent expert interpretation; lack of actionable guidance for non‑diabetics.
  • Industry/political influence: startups, lobbying, Surgeon General nominee ties, population‑level campaigns.
  • Suggested integrations: targeted clinical use (periodic, supervised monitoring) vs. everyday consumerization.

• Hotline: Why modern gadgets look bland — reasons include convergence on “good enough” designs, user inertia, manufacturing economies, and lack of disruptive new hardware tech.

Notable quotes / memorable lines

• Ben McKenzie: “If money is trust and you're saying it’s a trustless currency, then you're saying… it's like a governmentless government or religionless religion.”
• On FTX: “He instructed one of his lieutenants to change the source code… one line of code… and he stole all the money.”
• Ben McKenzie summarizing crypto’s dominant uses: “It’s gambling and crime.”
• V Song on data harm: “I started going to social events and not eating anything because I was terrified… I couldn’t eat cake at friends' birthday parties.”
• David Pierce paraphrasing Keynes: “The market can stay irrational longer than you can stay liquid.”

Recommendations & action items (for listeners)

• Watch Ben McKenzie’s documentary Everyone Is Lying to You for Money for deeper reporting if you’re interested in crypto fraud and culture.
• If considering crypto:
  • Treat it as speculative gambling unless you have a clear, evidence‑backed use case.
  • Be skeptical of “trustless” rhetoric and of projects claiming to be fully decentralized.
  • Understand the regulatory/political risk and the concentration of holdings among whales and corporations.
• If considering a CGM (non‑diabetics):
  • Consult a clinician before buying/acting on continuous glucose data.
  • Use CGMs selectively (short supervised monitoring windows) rather than 24/7 consumerized tracking.
  • Watch for and guard against disordered eating or health anxiety driven by wearable feedback; involve mental‑health support if obsessive behaviors start.
  • Push for clearer clinical guidelines and better product design that distinguishes medical vs. wellness features.
• For policymakers and product teams:
  • Invest in peer‑reviewed studies to build clinical consensus for non‑diabetic CGM use.
  • Consider regulation/classification that balances innovation with safety (distinguish “digital screener” features vs. medical devices).
  • Design user interfaces and notification systems to minimize anxiety and misinterpretation for non‑clinical users.

Who should listen / why it matters

• People curious about the real risks and societal impacts of crypto (tech reporters, investors, regulators).
• Anyone considering consumer CGMs or using wearables to monitor health — especially those prone to anxiety, disordered eating, or without clear medical need.
• Designers, product managers, and policymakers interested in the intersection of technology, health, and regulation.
• General listeners who want a skeptical, human take on two current tech phenomena: crypto mania and wearable health tech.

Episodes & next steps mentioned

• Ben McKenzie’s documentary Everyone Is Lying to You for Money (theatrical/streaming rollout).
• V Song’s longform reporting on CGMs in The Verge.
• Hotline: Submit questions to the VergeCast (866‑VERGE‑11 / vergecast@theverge.com).